Amelia, CEO and founder of BioGenX, arrives at the New York Hilton for an academic conference. Amelia has been travelling for more than 10 hours from her home town of Dresden in Germany. She is tired but her passion and drive is carrying her along. Amelia can’t contain her excitement. The conference brings together esteemed scientists and researchers in the field of genetic medicine, providing an ideal platform for BioGenX to showcase their ground-breaking discoveries and establish collaborations that will Amelia hopes will propel BioGenX on to the world stage.BioGenX's cutting-edge technology revolves around a revolutionary gene-editing algorithm, their most valuable intellectual property. This algorithm holds immense potential for treating genetic diseases and has garnered significant attention within parts of the industry. Additionally, BioGenX possesses sensitive research data, including genetic sequences and clinical trial results, which contribute to their competitive advantage.Anxious to settle in and review her notifications, Amelia finds a local desk in the hotel's designated conference area. The area is quite busy as the conference organizing team is setting up tables and chairs and delegates are milling around shaking hands and making introductions. She glances towards the main entry of the hotel where a limousine has pulled up. She recognizes one of the men stepping out of the car – it’s Pierre, the CEO of GenoDynamics, a large French firm that has been hitting the headlines with its own genetic engineering discoveries.Amelia realizes she is getting distracted. The cameras snapping away in the background aren’t helping. She opens up her laptop and a window pops up on the screen, prompting her to join the hotel's Wi-Fi network. Despite her better judgment, Amelia succumbs to the convenience and accepts the offer, hoping to limit her time online to do a quick check in case there were urgent messages. Amelia logs in to BioGenX’s VPN. She starts up her internal messaging platfom where an email marked ‘priority’ sits at the top of her queue. The email header says “Latest tweaks to the firm’s gene-editing algorithm”. Amelia opens up her email and begins to review the new algorithm. Just then a sudden wave of nausea strikes her. She knows she is going to throw up any second.  Overwhelmed by the discomfort, she instinctively rushes off to the washroom, leaving all her belongings behind in her haste.In the washroom, Amelia focuses on alleviating her discomfort. What was that about? She might have eaten something that didn’t set well with her stomach. She was feeling much better after throwing up. Amelia rushes back to the conference area, heart pounding with worry. To her immense relief, Amelia finds her handbag with her credit cards, identification documents and passports, and her laptop were still sitting on the table where she left it.The first panel discussion has already started. The topic is “Revolutionizing Gene Editing: A Glimpse into the Future”. Amelia is excited to be one of the panellists. A key topic being discussed is the effectiveness of various gene editing techniques. After the panel discussion, one of the panellists, Lisa, approaches Amelia. She is very impressed by Amelia’s arguments in favour of using RNA to target specific DNA sequences. Lisa confessed that she had been thinking of the same approach for some time but hadn’t been able to make it work. Amelia was so excited to get some attention! The two sat in a corner by themselves while Amelia explained how she overcame the key hurdles in getting RNA to make precise DNA modifications.

Case Scenario Amelia, CEO and founder of BioGenX, arrives at the New York Hilton for an academic conference. Amelia has been travelling for more than 10 hours from her home town of Dresden in Germany. She is tired but her passion and drive is carrying her along. Amelia can’t contain her excitement. The conference brings together esteemed scientists and researchers in the field of genetic medicine, providing an ideal platform for BioGenX to showcase their ground-breaking discoveries and establish collaborations that will Amelia hopes will propel BioGenX on to the world stage. BioGenX's cutting-edge technology revolves around a revolutionary gene-editing algorithm, their most valuable intellectual property. This algorithm holds immense potential for treating genetic diseases and has garnered significant attention within parts of the industry. Additionally, BioGenX possesses sensitive research data, including genetic sequences and clinical trial results, which contribute to their competitive advantage. Anxious to settle in and review her notifications, Amelia finds a local desk in the hotel's designated conference area. The area is quite busy as the conference organizing team is setting up tables and chairs and delegates are milling around shaking hands and making introductions. She glances towards the main entry of the hotel where a limousine has pulled up. She recognizes one of the men stepping out of the car – it’s Pierre, the CEO of GenoDynamics, a large French firm that has been hitting the headlines with its own genetic engineering discoveries. Amelia realizes she is getting distracted. The cameras snapping away in the background aren’t helping. She opens up her laptop and a window pops up on the screen, prompting her to join the hotel's Wi-Fi network. Despite her better judgment, Amelia succumbs to the convenience and accepts the offer, hoping to limit her time online to do a quick check in case there were urgent messages. Amelia logs in to BioGenX’s VPN. She starts up her internal messaging platfom where an email marked ‘priority’ sits at the top of her queue. The email header says “Latest tweaks to the firm’s gene-editing algorithm”. Amelia opens up her email and begins to review the new algorithm. Just then a sudden wave of nausea strikes her. She knows she is going to throw up any second. Overwhelmed by the discomfort, she instinctively rushes off to the washroom, leaving all her belongings behind in her haste. In the washroom, Amelia focuses on alleviating her discomfort. What was that about? She might have eaten something that didn’t set well with her stomach. She was feeling much better after throwing up. Amelia rushes back to the conference area, heart pounding with worry. To her immense relief, Amelia finds her handbag with her credit cards, identification documents and passports, and her laptop were still sitting on the table where she left it. The first panel discussion has already started. The topic is “Revolutionizing Gene Editing: A Glimpse into the Future”. Amelia is excited to be one of the panellists. A key topic being discussed is the effectiveness of various gene editing techniques. After the panel discussion, one of the panellists, Lisa, approaches Amelia. She is very impressed by Amelia’s arguments in favour of using RNA to target specific DNA sequences. Lisa confessed that she had been thinking of the same approach for some time but hadn’t been able to make it work. Amelia was so excited to get some attention! The two sat in a corner by themselves while Amelia explained how she overcame the key hurdles in getting RNA to make precise DNA modifications. Part 1: Risk Register Requirement #1: Identify at least three to five risks. Prioritize these according to criticality. Carefully word the description of each risk to reference an asset, threat actor or threat, potential outcome or impact to the firm and sufficient context to understand the situation and/or differentiate with other scenarios. Requirement #2: Estimate probability of each risk using qualitative ratings (e.g., low, medium, high). Document your level of confidence with each estimation (low, medium, high). Make reasonable assumptions using common sense and logic in your estimations of probability and confidence. Please document these in your written justification (part 2). Requirement #3: Estimate impact of each risk using qualitative ratings (e.g., low, medium, high). Consider the different categories of impact that such a risk can have on the organization. Document your level of confidence with each estimation (low, medium, high). Make reasonable assumptions using common sense and logic in your estimations of impact and confidence. Please document these in your written justification (part 2). Note: Please present the risk register in a table format

Your taskCase ScenarioAmelia, CEO and founder of BioGenX, arrives at the New York Hilton for an academic conference. Amelia has been travelling for more than 10 hours from her home town of Dresden in Germany. She is tired but her passion and drive is carrying her along. Amelia can’t contain her excitement. The conference brings together esteemed scientists and researchers in the field of genetic medicine, providing an ideal platform for BioGenX to showcase their ground-breaking discoveries and establish collaborations that will Amelia hopes will propel BioGenX on to the world stage.BioGenX's cutting-edge technology revolves around a revolutionary gene-editing algorithm, their most valuable intellectual property. This algorithm holds immense potential for treating genetic diseases and has garnered significant attention within parts of the industry. Additionally, BioGenX possesses sensitive research data, including genetic sequences and clinical trial results, which contribute to their competitive advantage.Anxious to settle in and review her notifications, Amelia finds a local desk in the hotel's designated conference area. The area is quite busy as the conference organizing team is setting up tables and chairs and delegates are milling around shaking hands and making introductions. She glances towards the main entry of the hotel where a limousine has pulled up. She recognizes one of the men stepping out of the car – it’s Pierre, the CEO of GenoDynamics, a large French firm that has been hitting the headlines with its own genetic engineering discoveries.Amelia realizes she is getting distracted. The cameras snapping away in the background aren’t helping. She opens up her laptop and a window pops up on the screen, prompting her to join the hotel's Wi-Fi network. Despite her better judgment, Amelia succumbs to the convenience and accepts the offer, hoping to limit her time online to do a quick check in case there were urgent messages. Amelia logs in to BioGenX’s VPN. She starts up her internal messaging platfom where an email marked ‘priority’ sits at the top of her queue. The email header says “Latest tweaks to the firm’s gene-editing algorithm”. Amelia opens up her email and begins to review the new algorithm. Just then a sudden wave of nausea strikes her. She knows she is going to throw up any second.  Overwhelmed by the discomfort, she instinctively rushes off to the washroom, leaving all her belongings behind in her haste.In the washroom, Amelia focuses on alleviating her discomfort. What was that about? She might have eaten something that didn’t set well with her stomach. She was feeling much better after throwing up. Amelia rushes back to the conference area, heart pounding with worry. To her immense relief, Amelia finds her handbag with her credit cards, identification documents and passports, and her laptop were still sitting on the table where she left it.The first panel discussion has already started. The topic is “Revolutionizing Gene Editing: A Glimpse into the Future”. Amelia is excited to be one of the panellists. A key topic being discussed is the effectiveness of various gene editing techniques. After the panel discussion, one of the panellists, Lisa, approaches Amelia. She is very impressed by Amelia’s arguments in favour of using RNA to target specific DNA sequences. Lisa confessed that she had been thinking of the same approach for some time but hadn’t been able to make it work. Amelia was so excited to get some attention! The two sat in a corner by themselves while Amelia explained how she overcame the key hurdles in getting RNA to make precise DNA modifications.Assignment TasksYour task is to write a risk assessment and control document for BioGenx arising from the above scenario. Assume that BioGenX has pursued a product-first approach since inception and hasn't invested back into their underlying organisational processes and infrastructure so their cybersecurity practice is immature.The document should consist of the following four sections with the applicable word limits:Part 1: Risk Register (approx. 250 words)Part 2: Justification of Risks (approx. 500 words)Part 3: Risk Control Strategy (approx. 500 words)Part 4: Personal Reflection (approx. 250 words)Part 1: Risk Register (250 words)Requirement #1: Identify at least three to five risks. Prioritize these according to criticality. Carefully word the description of each risk to reference an asset, threat actor or threat, potential outcome or impact to the firm and sufficient context to understand the situation and/or differentiate with other scenarios.Requirement #2: Estimate probability of each risk using qualitative ratings (e.g., low, medium, high). Document your level of confidence with each estimation (low, medium, high). Make reasonable assumptions using common sense and logic in your estimations of probability and confidence. Please document these in your written justification (part 2).Requirement #3: Estimate impact of each risk using qualitative ratings (e.g., low, medium, high). Consider the different categories of impact that such a risk can have on the organization. Document your level of confidence with each estimation (low, medium, high). Make reasonable assumptions using common sense and logic in your estimations of impact and confidence. Please document these in your written justification (part 2).Note: Please present the risk register in a table formatPart 2: Justification of Risk Assessment (500 words)Requirement #4: To complete your risk assessment please justify how you identified and selected the risks. Document the assumptions and logic used to estimate probability and impact and determine confidence levels. Document the categories of impact considered and weightings applied.Part 3: Risk Control Strategy (500 words)Requirement #5: Describe your strategy for controlling one risk of your choosing from the risk register. How will you use formal, informal and technological controls to best advantage? How effective do you think the controls will be and what might be the residual risk after controls are applied? What assumptions can you make about the firm’s risk appetite? What issues might arise given the subject in the scenario is the CEO and founder of BioGenX? How can these issues be handled?Part 4: Personal Reflection (250 words)Requirement #6: Reflect on your experience doing this risk assessment. What were the key challenges you faced? How did you overcome them? How did your personal perceptions of the risks in the scenario and risk management strategies impact your estimation of risk and choice of controls for BioGenX?

Which of the following is a successful medtech start-up? Amber Dixon Practo Swiggy

For many years, Amelia Airheart ran a boutique hotel in the Perth Hills. Around three years ago, Amelia decided to sell the business and retire. She advertised the business in the local newspaper, describing it as ‘an exciting business opportunity’. Bonnie Boeing saw the advertisement and expressed an interest in buying the hotel. At a meeting, Amelia gave Bonnie the financial records of the business and told her that it was very successful due to its loyal customer base. She added: ‘the rooms are getting a little shabby but with a spruce up and some good marketing you will be able to grow the business even further’. The financial records for the business showed that profits had declined somewhat in recent years but were still healthy. In fact, Amelia had doctored the records. The business had been running at a loss for many years and Amelia was desperate to get it off her hands. Bonnie agreed to buy the hotel for the full asking price of $5 million. She then invested a further $500,000 renovating each of the ten rooms. She replaced all of the carpets, light fittings and curtains, and repainted every room. Bonnie also spent $250,000 updating the plumbing throughout the hotel. When the renovations were complete, she paid another $50,000 for a full page advertisement in the local newspaper, proudly announcing that the hotel was under new management and had re-opened for business. For the next few months, business was slow. By the end of Bonnie’s first year in business there were so few bookings that she made a substantial loss. The losses increased in the next year, and the next. In despair, Bonnie telephoned Amelia. She said: ‘I’m failing here! Can you help?’ Amelia replied: ‘Afraid not. I knew that hotel was a loser. I hadn’t made a profit for years’. Shocked, Bonnie said: ‘I can’t believe you lied to me. I want my money back – now!’ However, Bonnie struggled on for another year before seeking legal advice. Her lawyer told her to immediately walk away from the business and commence proceedings against Amelia. He drafted the writ for her, claiming ‘rescission and/or damages for deceit’. Amelia, meanwhile, invested the $5 million sale price for the hotel in an acreage of land in the forest. She planned to build a large house on the block in which she would see out her retirement. She contracted with Charles Chindberg to construct the house. Charles subcontracted the whole job to Donald Douglas. The contract between Charles and Donald provided for a contract price of $500,000, with $100,000 to be paid up-front and the balance at completion. Donald commenced work, even though Charles had not paid the $100,000 instalment. A couple of days into the job, Donald discovered that the site sat on a bed of caprock which would have to be removed. He informed Charles, saying: ‘This will blow out the budget. We’re talking at least an extra $50,000’. Charles replied: ‘Ah - these things happen. I’ll run it past Amelia but your estimate sounds OK’. Donald didn’t hear back from Charles so got on with the caprock removal. The caprock turned out to be even more extensive than Donald had anticipated and cost $100,000 to remove. About a year later, Donald finished the job and sent Charles an invoice for $600,000. Charles forwarded it to Amelia who exclaimed: ‘This isn’t what we agreed! I’m not paying this!’ Not having been paid by Amelia, Charles was unable to pay anything to Donlad. Shortly afterwards, Charles became insolvent. Answer the following questions: 1. Can Bonnie rescind her contract with Amelia and, if so, what can she recover? 2. Does Donald have a claim for restitution against Amelia or Charles and, if so, in what amount?

Title: Navigating the Ethical Terrain of Human Genetic Engineering: Balancing Possibilities, Risks and Equities Introduction A brief overview of genetic engineering and its potential in humans Introduction to CRISPR-Cas9 and its significance A preview of the ethical considerations and social implications to be discussed. II Understanding the potential benefits Exploring potential medical breakthroughs through genetic engineering Examples of diseases that can potentially be treated or prevented. Addition of desirable traits and the concept of genetic enhancement Discuss how genetic engineering can contribute to advances in personalized medicine III Assessing Risks and Ethical Concerns Examination of potential risks associated with genetic engineering, including unintended mutations and off-target effects Ethical concerns related to germ cell modification and implications for future generations Consider the potential for abuse, including eugenics and designer babies Discussion of concerns regarding consent, autonomy, and potential for discrimination IV Navigating Ethical Dilemmas Exploring ethical frameworks for evaluating human genetic engineering, including utilitarianism, deontology, and ethics Discuss the importance of public engagement and dialogue in the formulation of ethical guidelines and policies Consideration of regulatory frameworks and international cooperation in managing ethical dilemmas An examination of the role of health care professionals, scientists, policy makers, and ethicists in addressing ethical challenges. V. To ensure equity and guard against unintended consequences Discuss the importance of equitable access to genetic technologies and health care services Consideration of socio-economic disparities and the potential for widening existing inequalities Exploring strategies to ensure transparency, accountability, and oversight in genetic research and applications Evaluation of the role of education and public awareness in promoting the responsible use of genetic technologies VI CONCLUSION Summary of key points discussed regarding the ethical implications of human genetic engineering A call for continued interdisciplinary collaboration and ethical reflection in the development and application of genetic technologies Emphasis on the importance of balancing the potential benefits of genetic engineering with ethical considerations and societal values This outline provides a systematic approach to addressing the overarching question you pose, allowing for an in-depth exploration of the ethical implications of genetic engineering in humans. short Introduction fairy II Potential benefits of genetic engineering in humans Former Discs Exam A III Risks and Ethical Concerns identity Ethical Discussion of IV Navigating Ethical Dilemmas Exploration a Examination Ampo V. Ensuring Equitable Access and Protecting Against Unintended Consequences Discussion of th Examination Street VI CONCLUSION Again Emphasizes the need for a ba